Intracerebral Hemorrhage Clinical Trial
Official title:
Safety and Tolerability of Deferoxamine in Acute Cerebral Hemorrhage
Animal studies show that the breakdown of blood results in iron accumulation in the brain
after brain hemorrhage (ICH); and that iron plays a role in brain injury in ICH patients.
Deferoxamine (DFO) has been extensively used in clinical practice for more than 30 years to
remove excessive iron from the body, and has been shown to provide some benefit in animal
studies of ICH. Therefore, we plan to undertake this study to evaluate the safety and
tolerability of treatment with DFO in patients with ICH, and to determine the maximal
tolerated dose to be used in future studies to determine if treatment with DFO can improve
the outcome of patients with ICH.
Our main objectives are: 1) to evaluate the safety and tolerability of varying doses of DFO,
by determining the treatment related adverse events, in patients with ICH; and 2) to
determine the maximal tolerated dose to be adopted in subsequent studies to test the efficacy
of DFO in improving outcome after ICH.
We hypothesize that DFO is well-tolerated and has minimal serious adverse effects in patients
with ICH; and that treatment with DFO will improve patients' outcome. The results can
potentially bring into account new means to improve the outcome of patients with ICH. ICH is
a frequent cause of disability and death. A successful study demonstrating the efficacy of
iron-modifying therapy would be of considerable public health significance.
An open-label, safety, tolerability, and dose-finding study using the continuous reassessment method. ;
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Recruiting |
NCT05089331 -
ROSE-Longitudinal Assessment With Neuroimaging
|
||
| Recruiting |
NCT03605381 -
MORbidity PRevalence Estimate In StrokE
|
||
| Active, not recruiting |
NCT04522102 -
Antiplatelet Secondary Prevention International Randomised Trial After INtracerebral haemorrhaGe (ASPIRING)-Pilot Phase
|
Phase 3 | |
| Terminated |
NCT04178746 -
PRONTO: Artemis in the Removal of Intraventricular Hemorrhage in the Hyper-Acute Phase
|
||
| Not yet recruiting |
NCT03956485 -
Multicentre Registry of Patients With Spontaneous Acute Intracerebral Hemorrhage in Catalonia (HIC-CAT).
|
||
| Enrolling by invitation |
NCT02920645 -
Multicenter Validation of the AVICH Score
|
N/A | |
| Recruiting |
NCT02625948 -
Tranexamic Acid for Acute ICH Growth prEdicted by Spot Sign
|
Phase 2 | |
| Completed |
NCT02478177 -
Addressing Real-world Anticoagulant Management Issues in Stroke
|
||
| Completed |
NCT01971359 -
Clinical Outcomes Following Parafascicular Surgical Evacuation of Intracerebral Hemorrhage: A Pilot Study
|
N/A | |
| Terminated |
NCT00990509 -
Albumin for Intracerebral Hemorrhage Intervention
|
Phase 2 | |
| Completed |
NCT01261091 -
Early Tracheostomy in Ventilated Stroke Patients
|
N/A | |
| Completed |
NCT00716079 -
The Second Intensive Blood Pressure Reduction in Acute Cerebral Haemorrhage Trial
|
N/A | |
| Recruiting |
NCT00222625 -
rFVIIa in ICH in Patients Treated With Anticoagulants or Anti-Platelets
|
Phase 2 | |
| Recruiting |
NCT05095857 -
The Anesthetic Ketamine as Treatment for Patients With Severe Acute Brain Injury
|
Phase 4 | |
| Recruiting |
NCT04548596 -
NOninVasive Intracranial prEssure From Transcranial doppLer Ultrasound Development of a Comprehensive Database of Multimodality Monitoring Signals for Brain-Injured Patients
|
||
| Not yet recruiting |
NCT06429332 -
International Care Bundle Evaluation in Cerebral Hemorrhage Research
|
Phase 4 | |
| Recruiting |
NCT05492474 -
Cranial Ultrasound for Prehospital ICH Diagnosis
|
N/A | |
| Not yet recruiting |
NCT05502874 -
Multicenter Registry for Assessment of Markers of Early Neurological Deterioration in Primary Intracerebral Hemorrhage
|
||
| Recruiting |
NCT04604587 -
MRI-visible Enlarged Perivascular Spaces and the Alteration of Lymphatic Drainage System in CAA
|
Phase 3 | |
| Recruiting |
NCT05504941 -
Detection of an Endovascular Treatment Target in Patients With an Acute, Spontaneous Intracerebral Hemorrhage
|
N/A |